TROP2 Is Uniformly Expressed in Primary Prostate Cancer but Frequently Reduced in Recurrent Disease.

Saved in:
Bibliographic Details
Title: TROP2 Is Uniformly Expressed in Primary Prostate Cancer but Frequently Reduced in Recurrent Disease.
Authors: Jeutner J; Department of Urology, Charité-University Medical Center Berlin, 10117 Berlin, Germany., Simon R; Institute of Pathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Lennartz M; Institute of Pathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Minner S; Institute of Pathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Burandt E; Institute of Pathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Gehrisch F; Institute of Pathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Schraps N; Institute of Pathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Kluth M; Institute of Pathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Sauter G; Institute of Pathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Plage H; Department of Urology, Charité-University Medical Center Berlin, 10117 Berlin, Germany., Schmidt J; Department of Urology, Charité-University Medical Center Berlin, 10117 Berlin, Germany., Gorbokon N; Institute of Pathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Viehweger F; Institute of Pathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Heinzer H; Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Haese A; Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Schlomm T; Department of Urology, Charité-University Medical Center Berlin, 10117 Berlin, Germany., Graefen M; Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Steurer S; Institute of Pathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Schlichter R; Institute of Pathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Bernreuther C; Institute of Pathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Dum D; Institute of Pathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Luebke A; Institute of Pathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Ralla B; Department of Urology, Charité-University Medical Center Berlin, 10117 Berlin, Germany., Heckmann N; Institute of Pathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Source: Cancers [Cancers (Basel)] 2026 Jul 22; Vol. 18 (14). Date of Electronic Publication: 2026 Jul 22.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2072-6694
DOI:10.3390/cancers18142359